Shattuck Labs (STTK) EBT Margin Growth (3y) (2022 - 2025)

Shattuck Labs (STTK) EBT Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 9,237.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -408.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -120.00
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Shattuck Labs 831.66 Mn 831.66 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 1.38 Mn
Sep 30, 2024 130,322.00
Jun 30, 2024 -33,767.00
Mar 31, 2024 -122,136.00
Dec 31, 2023 -1.12 Mn
Sep 30, 2023 -335,164.00
Jun 30, 2023 -1.13 Mn
Mar 31, 2023 -3.81 Mn
Dec 31, 2022 -613,404.00
Sep 30, 2022 -1.45 Mn